Articles On Zelda Therapeutics (ASX:ZLD)
| Title | Source | Codes | Date |
|---|---|---|---|
|
Approval for Zelda's new clinical trial
Zelda Therapeutics (ASX:ZLD) has announced that its phase 1 Opioid Reduction Trial has been formally approved by the St Vincent’s Hospital Ethics and Governance Committees. |
BiotechDispatch | ZLD | 5 years ago |
|
Could medicinal cannabis curb the opioid crisis?
One of Australia's leading cannabis companies Zelda Therapeutics (ASX: ZLD) has been given the greenlight to commence an opioid reduction trial. The trial at St Vincent's Hospital in Melbourne will see Zelda assess the effectiveness of me... |
BusinessNewsAus | ZLD | 5 years ago |
|
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | ZLD | 5 years ago |
|
Weed Week: Here comes the latest hot take on legal dope from… the Country Women’s Association
Australian cinephiles have two silver screen shows made just for the cannabis crowd to watch. Feature-length film ‘High as Mike’ traces one Tamworth man’s difficult undertaking to access medical cannabis to treat his brain cancer. And the... |
Stockhead | ZLD | 5 years ago |
|
Zelda Therapeutics gains new strategic investor in Merchant Funds Management
The company’s medicinal cannabis products are aimed at treating pain, anxiety, sleep apnea and cancer. |
Proactive Investors | ZLD | 5 years ago |